Skip to main content

Peer Review reports

From: Paxlovid use is associated with lower risk of cardiovascular diseases in COVID-19 patients with autoimmune rheumatic diseases: a retrospective cohort study

Original Submission
8 Nov 2023 Submitted Original manuscript
3 Dec 2023 Reviewed Reviewer Report
7 Dec 2023 Reviewed Reviewer Report
12 Dec 2023 Reviewed Reviewer Report
29 Jan 2024 Author responded Author comments - Weijie Wang
Resubmission - Version 2
29 Jan 2024 Submitted Manuscript version 2
30 Jan 2024 Reviewed Reviewer Report
29 Feb 2024 Author responded Author comments - Weijie Wang
Resubmission - Version 3
29 Feb 2024 Submitted Manuscript version 3
Publishing
29 Feb 2024 Editorially accepted
13 Mar 2024 Article published 10.1186/s12916-024-03331-0

You can find further information about peer review here.

Back to article page